NASDAQ:KRMD KORU Medical Systems Q3 2026 Earnings Date & Estimates $3.10 +0.05 (+1.64%) As of 02:14 PM Eastern This is a fair market value price provided by Massive. Learn more. KORU Medical Systems is scheduled to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 10, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from KORU Medical Systems in Q3 2026KORU Medical Systems is expected to post earnings of -$0.0168 per share on revenue of $11.33 million. KORU Medical Systems last reported on August 5, 2026, posting $0.01 per share and beating the -$0.0180 consensus estimate. KORU Medical Systems has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.0168Expected Revenue$11.33 millionRecent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.01 (Beat by +$0.0280)Last Quarter Revenue$12.05 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ4 2025 Earnings ReportQ2 2025 Earnings Report KORU Medical Systems Q3 2026 Earnings FAQ When does KORU Medical Systems report Q3 2026 earnings? KORU Medical Systems (NASDAQ:KRMD) has confirmed it will report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. What time is KORU Medical Systems' Q3 2026 earnings call? KORU Medical Systems' Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for KORU Medical Systems? Analysts expect KORU Medical Systems to post earnings of -$0.0168 per share for Q3 2026. How much revenue is KORU Medical Systems expected to report? The consensus revenue estimate for KORU Medical Systems is $11.33 million for Q3 2026. KORU Medical Systems Earnings HeadlinesKORU Medical Systems (NASDAQ:KRMD) and Bausch + Lomb (NYSE:BLCO) Critical SurveyOctober 26, 2026 | americanbankingnews.comKORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026October 20, 2026 | businesswire.comYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.November 3 at 1:00 AM | Behind the Markets (Ad)Koru Medical Systems Inc Share Price (KRMD.US)October 15, 2026 | lse.co.ukKORU Medical Systems Selloff Offers An OpportunityAugust 22, 2026 | seekingalpha.comKORU (KRMD) Q2 2026 Earnings Call TranscriptAugust 12, 2026 | finance.yahoo.comSee More KORU Medical Systems Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like KORU Medical Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on KORU Medical Systems and other key companies, straight to your email. Email Address About KORU Medical SystemsKORU Medical Systems (NASDAQ:KRMD) develops, manufactures and markets portable infusion systems and related accessories for the home and alternate-site infusion markets. The company’s products are designed to support the controlled delivery of specialty drugs, including subcutaneous immunoglobulin (SCIG) therapies, through ambulatory infusion systems. KORU’s principal product platform is the Freedom Syringe Infusion System, which includes ambulatory syringe pumps such as the Freedom60, FreedomEdge and FreedomIQ, along with flow-control tubing sets and other disposable components. These products are intended to provide patients and caregivers with portable, low-maintenance infusion options that can be used outside traditional clinical settings. Based in Milford, Connecticut, KORU serves patients, healthcare providers, specialty pharmacies and home-infusion organizations in the United States and international markets. The company’s products are used primarily in the treatment of chronic conditions requiring ongoing infusion therapy, with an emphasis on improving convenience and supporting at-home care.View KORU Medical Systems ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir's $2.3 Billion Quarter Puts Its Premium Valuation to the TestRepublic Services Has the Momentum, But Waste Management Has Another AdvantageAre the Fears Around Alphabet’s Search Slowdown Warranted?Alphabet's Golden Dome Talks Could Open a New Market, But How Much Is at Stake?Streaming Success: Fox Corp Channels Tubi For Q1 Earnings BeatCheck Point's Turnaround Could Be Closer Than Investors ThinkTempus AI Surges on Earnings Beat, But Can the Rally Last? Upcoming Earnings McDonald's (11/4/2026)DoorDash (11/4/2026)MercadoLibre (11/4/2026)Cenovus Energy (11/4/2026)Aflac (11/4/2026)Allstate (11/4/2026)MetLife (11/4/2026)Manulife Financial (11/4/2026)Cencora (11/4/2026)CVS Health (11/4/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
